Similarly, inhibiting ClpP in leukemic cells leads to abnormal protein accumulation and causes cell death45, while the excessive activation of ClpP results in ETC degradation, which synergistically enhances the ferroptosis of leukemia cells in conjunction with GPX4 inhibition46. The gene discussed is CLPP; the disease is leukemia.